Our data revealed that over-expression of ALDH2 enzyme confers a neuroprotective effect against rotenone-induced neuronal death and that ALDH2 small molecule activators, like Alda-1, may serve as a therapeutic agent for PD in the future. Here, ALDH2 is linked to Parkinson disease.